Trial intelligence / Profile preview

TDM of Generic Lopinavir/Ritonavir Tablets in Thai HIV Patients

NCT00802334Phase 2Completed

Sponsor
HIV-NAT
Start
Jan 2008
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jan 2008; status: completed.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00802334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00802334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call